Emily Lau, MD, is a member of the class of 2021 in the Cardiovascular Disease Fellowship Program at Massachusetts General Hospital. Dr. Lau shares what drew her to Mass General, the culture of the program and her experience as a trainee during the COVID-19 pandemic.
Corrigan Minehan Heart Center
Explore This Research Lab
Cardiovascular disease, largely due to coronary artery disease, is the leading cause of death in the U.S. and worldwide.
The Natarajan Laboratory at Massachusetts General Hospital uses genomics, biomarkers, bioinformatics, mobile technology, and deep phenotypic learning to discover and understand the causal factors of atherosclerotic cardiovascular disease across diverse populations. These insights are implemented into prospective studies to improve cardiovascular care.
The lab spans the Massachusetts General Hospital Cardiovascular Research Center and Center for Genomic Medicine, Program in Medical & Population Genetics of the Broad Institute of Harvard and MIT, and Harvard Medical School.
For details about our work, including publications, available research positions, and more information for patients, please visit the Natarajan Lab’s main website.
Meet Our Team
Pradeep Natarajan, MD, MMSc, Principal Investigator and Director of Preventive Cardiology at Massachusetts General Hospital, where he oversees prevention, genetics, and cardiac rehabilitation programs for atherosclerotic cardiovascular disease.
Phoebe Finneran, BS, Clinical Research Coordinator
Akhil Pampana, MS, Computational Biologist
Maryam Zekavat, BS, Yale MD/PhD Student
- Press Release
- Aug | 25 | 2020
Massachusetts General Hospital first in New England to perform new procedures for tricuspid valve disease
Massachusetts General Hospital (MGH) is announcing two first-of-their-kind procedures in New England today, to treat one of the most common forms of heart valve disease.
- Press Release
- Aug | 19 | 2020
Clinical and sociodemographic features of early COVID-19 patients in Massachusetts: MGH study suggests vulnerable populations are hardest hit
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
- Jun | 23 | 2020
As the initial surge of the COVID-19 pandemic subsides, Massachusetts General Hospital leaders are discussing the transition to strategies for recovery and wellness.
- Press Release
- Jun | 2 | 2020
A team led by investigators at Mass General and the Broad Institute of MIT and Harvard recently found that applying “polygenic risk scores” can identify at-risk patients who are not presently identified through standard clinical evaluations.
- Patient Education
- May | 27 | 2020
During the COVID-19 pandemic, the Mass General Corrigan Minehan Heart Center is providing general and surgical care for our patients. We have taken unprecedented steps to ensure all office visits, procedures and surgeries are welcoming and safe. We have also expanded our virtual visit offerings.